161 related articles for article (PubMed ID: 19594492)
1. Markers aiding the diagnosis of chondroid tumors: an immunohistochemical study including osteonectin, bcl-2, cox-2, actin, calponin, D2-40 (podoplanin), mdm-2, CD117 (c-kit), and YKL-40.
Daugaard S; Christensen LH; Høgdall E
APMIS; 2009 Jul; 117(7):518-25. PubMed ID: 19594492
[TBL] [Abstract][Full Text] [Related]
2. Distinguishing chordoid meningiomas from their histologic mimics: an immunohistochemical evaluation.
Sangoi AR; Dulai MS; Beck AH; Brat DJ; Vogel H
Am J Surg Pathol; 2009 May; 33(5):669-81. PubMed ID: 19194275
[TBL] [Abstract][Full Text] [Related]
3. D2-40 functions as an effective chondroid marker distinguishing true chondroid tumors from chordoma.
Huse JT; Pasha TL; Zhang PJ
Acta Neuropathol; 2007 Jan; 113(1):87-94. PubMed ID: 17021752
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical comparison of chordoma with chondrosarcoma, myxopapillary ependymoma, and chordoid meningioma.
Cho HY; Lee M; Takei H; Dancer J; Ro JY; Zhai QJ
Appl Immunohistochem Mol Morphol; 2009 Mar; 17(2):131-8. PubMed ID: 19521276
[TBL] [Abstract][Full Text] [Related]
5. Expression of tau proteins and tubulin in extraskeletal myxoid chondrosarcoma, chordoma, and other chondroid tumors.
Hu B; McPhaul L; Cornford M; Gaal K; Mirra J; French SW
Am J Clin Pathol; 1999 Aug; 112(2):189-93. PubMed ID: 10439798
[TBL] [Abstract][Full Text] [Related]
6. Keratin subsets and monoclonal antibody HBME-1 in chordoma: immunohistochemical differential diagnosis between tumors simulating chordoma.
O'Hara BJ; Paetau A; Miettinen M
Hum Pathol; 1998 Feb; 29(2):119-26. PubMed ID: 9490269
[TBL] [Abstract][Full Text] [Related]
7. Chondroid chordomas and low-grade chondrosarcomas of the craniospinal axis. An immunohistochemical analysis of 17 cases.
Wojno KJ; Hruban RH; Garin-Chesa P; Huvos AG
Am J Surg Pathol; 1992 Dec; 16(12):1144-52. PubMed ID: 1463093
[TBL] [Abstract][Full Text] [Related]
8. Brachyury, SOX-9, and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysis.
Oakley GJ; Fuhrer K; Seethala RR
Mod Pathol; 2008 Dec; 21(12):1461-9. PubMed ID: 18820665
[TBL] [Abstract][Full Text] [Related]
9. Type II collagen, but not aggrecan expression, distinguishes clear cell chondrosarcoma and chondroblastoma.
Söder S; Oliveira AM; Inwards CY; Müller S; Aigner T
Pathology; 2006 Feb; 38(1):35-8. PubMed ID: 16484006
[TBL] [Abstract][Full Text] [Related]
10. Parachordoma is immunohistochemically and cytogenetically distinct from axial chordoma and extraskeletal myxoid chondrosarcoma.
Folpe AL; Agoff SN; Willis J; Weiss SW
Am J Surg Pathol; 1999 Sep; 23(9):1059-67. PubMed ID: 10478665
[TBL] [Abstract][Full Text] [Related]
11. Differential diagnosis of chordoma, chondroid, and ependymal tumors as aided by anti-intermediate filament antibodies.
Miettinen M; Lehto VP; Dahl D; Virtanen I
Am J Pathol; 1983 Aug; 112(2):160-9. PubMed ID: 6192722
[TBL] [Abstract][Full Text] [Related]
12. Chondroid chordoma--a variant of chordoma. A morphologic and immunohistochemical study.
Rosenberg AE; Brown GA; Bhan AK; Lee JM
Am J Clin Pathol; 1994 Jan; 101(1):36-41. PubMed ID: 7506477
[TBL] [Abstract][Full Text] [Related]
13. Discovered on gastrointestinal stromal tumour 1 (DOG1): a useful immunohistochemical marker for diagnosing chondroblastoma.
Akpalo H; Lange C; Zustin J
Histopathology; 2012 Jun; 60(7):1099-106. PubMed ID: 22335248
[TBL] [Abstract][Full Text] [Related]
14. Analysis of radiological features relative to histopathology in 42 skull-base chordomas and chondrosarcomas.
Pamir MN; Ozduman K
Eur J Radiol; 2006 Jun; 58(3):461-70. PubMed ID: 16631334
[TBL] [Abstract][Full Text] [Related]
15. S-100 protein immunostaining in the differential diagnosis of chondroblastoma.
Monda L; Wick MR
Hum Pathol; 1985 Mar; 16(3):287-93. PubMed ID: 2579018
[TBL] [Abstract][Full Text] [Related]
16. The impact of osteonectin for differential diagnosis of osteogenic bone tumors: an immunohistochemical and in situ hybridization approach.
Park YK; Yang MH; Park HR
Skeletal Radiol; 1996 Jan; 25(1):13-7. PubMed ID: 8717113
[TBL] [Abstract][Full Text] [Related]
17. [Immunohistochemical differentiation of leiomyocellular tumors and tumors with myogenic differentiation].
Povýsil C; Ciprová V; Dundr P; Horáková M
Cesk Patol; 2003 Apr; 39(2):64-8. PubMed ID: 12874903
[TBL] [Abstract][Full Text] [Related]
18. Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors.
Naka T; Iwamoto Y; Shinohara N; Ushijima M; Chuman H; Tsuneyoshi M
Mod Pathol; 1997 Aug; 10(8):832-8. PubMed ID: 9267827
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical investigation of chordomas: histogenetic and differential diagnostic aspects.
Bouropoulou V; Bosse A; Roessner A; Vollmer E; Edel G; Wuisman P; Härle A
Curr Top Pathol; 1989; 80():183-203. PubMed ID: 2776494
[TBL] [Abstract][Full Text] [Related]
20. The H3F3 K36M mutant antibody is a sensitive and specific marker for the diagnosis of chondroblastoma.
Amary MF; Berisha F; Mozela R; Gibbons R; Guttridge A; O'Donnell P; Baumhoer D; Tirabosco R; Flanagan AM
Histopathology; 2016 Jul; 69(1):121-7. PubMed ID: 26844533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
